Cytomegalovirus (CMV) infection is one of the most common herpesvirus infections with a variety of symptoms, affecting people of all ages around the world. This viral infection is contagious and can be spread easily through body fluids such as blood, urine, saliva, semen, and breast milk. The infection can spread easily through saliva or urine, and people with CMV may have the virus in their saliva or urine for several months. The disease can be transmitted from pregnant women to babies during childbirth. Blood transfusions and transplantation of infected organs are other ways of spreading the disease.
Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17356
Infection can be diagnosed through serological tests such as enzyme-linked immunoassay. Many cases of CMV are not diagnosed in the early stages of infection, so awareness of the infection is the most important factor. According to the Centers for Disease Control and Prevention (CDC), about 150 infants are born with cytomegalovirus infection each year in the United States, and few of them have long-term health problems.
A key factor responsible for the growth of cytomegalovirus infection is the increasing public awareness associated with herpesvirus infection, which is increasing diagnostic rates in North America and Europe. North America was observed as the largest market for the treatment of cytomegalovirus infection after Europe. Asia Pacific is projected to grow at the fastest CAGR during the forecast period. The key factors supporting the growth of the Asia Pacific cytomegalovirus infection treatment market are increasing awareness related to rare diseases, development of medical infrastructure, high disposable income, and government support for new treatments for rare genetic diseases.
Request Table of Contents @ https://www.persistencemarketresearch.com/toc/17356
Cytomegalovirus Infection Market: Segmentation
| depending on the drug type |
|
| depending on the type of infection |
|
| Distribution Channel Standard |
|
Based on product type, the market is segmented into Cidofovir, Foscarnet, Valganciclovir and Ganciclovir. These are some of the most commonly prescribed drugs for the treatment of cytomegalovirus. Similarly, based on distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to retain the largest share of the market owing to the ease of availability of drugs and increasing prescription patterns for the treatment of CMV.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/17356
Geographically, the global cytomegalovirus infection market is segmented into North America, Latin America, Western Europe, Eastern Europe, Japan and Asia Pacific excluding Japan, Middle East and Africa. The growth of CMV virus is attributable to increased awareness of the herpes virus and the increased diagnosis rate in developed countries such as North America and Europe. Likewise, government initiatives to raise awareness of the disease, rising healthcare spending and rising disposable income are some of the factors driving the market growth in the Asia Pacific region.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com